Pharmacological targeting of ageing hallmarks: molecular mechanism and clinical translation
Background: Ageing is a gradual biological process characterized by progressive physiological decline and increased susceptibility to age-related diseases. The hallmarks of ageing provide a mechanistic framework for understanding these changes and identifying potential therapeutic targets. Objective: This review summarizes the major hallmarks of ageing, their links to age-related diseases, and pharmacological strategies targeting these mechanisms. Methods: We provide a narrative synthesis of current mechanistic and clinical evidence on candidate gerotherapeutics. Results: Pharmacological interventions targeting nutrient sensing, cellular senescence, mitochondrial dysfunction, and other aging-related pathways include metformin, rapamycin, senotherapeutics, and NAD+ precursors. These agents show potential to improve healthspan and reduce disease burden, although human evidence remains heterogeneous. Conclusion: Targeting the hallmarks of ageing represents a promising therapeutic strategy, but further well-designed clinical studies are needed to establish efficacy, safety, and clinically meaningful benefits.
Authors
- Hongyao Li (ORCID: https://orcid.org/0009-0007-8195-0452)
- 苏琳
- Xiuying Yan
Publication Details
- Journal
- Figshare
- Published
- 2026-11-17
- DOI
- https://doi.org/10.6084/m9.figshare.35038607
- Primary Topic
- Genetics, Aging, and Longevity in Model Organisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00